Designer immune-cell therapy could shrink deadly brain tumors, early trials show

[admin]

Two early clinical trials that together included nine patients suggest that a treatment called CAR-T therapy could treat glioblastoma, but its long-term effects are unknown.

Designer immune-cell therapy could shrink deadly brain tumors, early trials show : Read more